This R21 application seeks to determine if infection-sensiztied perinatal hypoxic-ischemic injury promotes monocyte invasion of the CNS to induce acute brain injury and conversion to a microglia-like sub-inflammatory state. This is a significant subject because little is known about monocyte-micorglia interactions/transformation in the neomnatal brain and pro-inflammatory monocyte-derivatives may increase the brain susceptibility to kindling and convulsion after injury. Further, understanding how infiltrating monocytes contribute to injury may lead to novel therapeutic strategies. In this project, we will test the hypothesis that perinatal infection/hypoxic-ischemic injury promotes monocytes to invade the CNS and exert inflammatory and destructive actions. Later, some of these monocytes adopt the microglial identity but are locked-in in a pro-inflammatory state to raise the brain susceptibility to excitotoxins and the kindling to convulsions. We will test this hypothesis n two specific aims.
Aim 1 : Significance of invading monocytes in acute infection/HI brain injury of newborns. We will use bitransgenic CX3CR1-GFP: CCR2-RFP mice to label microglia and monocytes respectively, and subject these mice to endotoxin (LPS)-sensitized hypoxia-ischemia (HI) injury to test the influx of monocytes in neonatal brains and their expression of pro-inflammatory cytokines. Next, we will compare the responses by hemizygous CCR2RFP/+ and homozygous CCR2RFP/RFP mice (equivalent to CCR2-null and lacking the receptor for Monocyte Chemoattractant Protein-1) to LPS/HI insult, as well as the benefits of anti-CCR2 antagonists to assess the pathogenic role of monocytes.
Aim 2 : Developmental consequences of monocyte influx after perinatal infection/HI brain injury. We will intravenously transfer actin-GFP/CCR2-RFP monocytes into LPS/HI-injured murine pups and follow their developmental outcomes. Based on the GFP-revealed morphology and double labeling with anti-cytokine antibody, we wiil test whether monocytes convert to microglia and maintain a pro-inflammatory state in adult brains. Next, we will use CCR2-mutant mice and a selective CCR2 antagonist (RS102895), to test whether or not monocyte-derived microglia sensitize the brain response to the kainic acid excitotoxicity and PTZ-induced kindling to convulsions.

Public Health Relevance

Perinatal brain injury contributes to cognitive deficits, but the underlying mechnaisms remain poorly understood. The recent discovery that (a) microglia survey and modulate the neural circuitry and (b) monocytes normally do not convert to microglia after birth raises an intriguing possibility that perinatal brian injury may recruit monocytes into immature brains to exert both short- and long-term damaging effects. The present project will test this hypothesis in murine models and examine a novel therapy aimed at blocking the monocyte influx after perinatal brain injury. Positive outcomes of this project will therefore benefit the public health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS093446-02
Application #
9198866
Study Section
Cellular and Molecular Biology of Glia Study Section (CMBG)
Program Officer
Koenig, James I
Project Start
2016-01-01
Project End
2017-12-31
Budget Start
2017-01-01
Budget End
2017-12-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Emory University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322